Rayner O - Search Results

1

Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials.

Davies G, Rowbotham NJ, Smith S, Elliot ZC, Gathercole K, Rayner O, Leighton PA, Herbert S, Duff AJ, Chandran S, Daniels T, Nash EF, Smyth AR. Davies G, et al. Among authors: rayner o. J Cyst Fibros. 2020 May;19(3):499-502. doi: 10.1016/j.jcf.2019.10.025. Epub 2019 Nov 15. J Cyst Fibros. 2020. PMID: 31735561 Free article.

2

Working in partnership with the patient community to develop outline trial designs in CF.

Rowbotham NJ, Smith S, Davies G, Leighton P, Rayner O, Elliott Z, Daniels T, Smyth AR. Rowbotham NJ, et al. Among authors: rayner o. J Cyst Fibros. 2022 Mar;21(2):300-301. doi: 10.1016/j.jcf.2021.12.008. Epub 2021 Dec 16. J Cyst Fibros. 2022. PMID: 34924317 Free article. No abstract available.

3

Can exercise replace airway clearance techniques in cystic fibrosis? A survey of patients and healthcare professionals.

Rowbotham NJ, Smith SJ, Davies G, Daniels T, Elliott ZC, Gathercole K, Rayner OC, Smyth AR. Rowbotham NJ, et al. Among authors: rayner oc. J Cyst Fibros. 2020 Jul;19(4):e19-e24. doi: 10.1016/j.jcf.2019.10.026. Epub 2019 Nov 15. J Cyst Fibros. 2020. PMID: 31740105 Free article.

4

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.

Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott ZC, Nash EF, Daniels T, Duff AJA, Collins S, Chandran S, Peaple U, Hurley MN, Brownlee K, Smyth AR. Rowbotham NJ, et al. Among authors: rayner oc. Thorax. 2018 Apr;73(4):388-390. doi: 10.1136/thoraxjnl-2017-210473. Epub 2017 Aug 4. Thorax. 2018. PMID: 28778919 Free PMC article.

5

Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis.

Rowbotham NJ, Smith SJ, Elliott ZC, Leighton PA, Rayner OC, Morley R, Smyth AR. Rowbotham NJ, et al. Among authors: rayner oc. Res Involv Engagem. 2019 Aug 20;5:24. doi: 10.1186/s40900-019-0159-x. eCollection 2019. Res Involv Engagem. 2019. PMID: 31452934 Free PMC article.

6

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

Rosenfeld M, Rayner O, Smyth AR. Rosenfeld M, et al. Among authors: rayner o. Cochrane Database Syst Rev. 2020 Sep 30;9(9):CD001912. doi: 10.1002/14651858.CD001912.pub5. Cochrane Database Syst Rev. 2020. PMID: 32997797 Free PMC article.

7

Opportunities for machine learning to transform care for people with cystic fibrosis.

Abroshan M, Alaa AM, Rayner O, van der Schaar M. Abroshan M, et al. Among authors: rayner o. J Cyst Fibros. 2020 Jan;19(1):6-8. doi: 10.1016/j.jcf.2020.01.002. J Cyst Fibros. 2020. PMID: 32000972 Free article. No abstract available.

8

Oral calorie supplements for cystic fibrosis.

Smyth RL, Rayner O. Smyth RL, et al. Among authors: rayner o. Cochrane Database Syst Rev. 2014 Nov 3;(11):CD000406. doi: 10.1002/14651858.CD000406.pub4. Cochrane Database Syst Rev. 2014. PMID: 25363148 Updated. Review.

9

Oral calorie supplements for cystic fibrosis.

Smyth RL, Rayner O. Smyth RL, et al. Among authors: rayner o. Cochrane Database Syst Rev. 2017 May 4;5(5):CD000406. doi: 10.1002/14651858.CD000406.pub5. Cochrane Database Syst Rev. 2017. PMID: 28470972 Free PMC article. Review.

10

A mixed methods study of the administration of flucloxacillin oral liquid; identifying strategies to overcome administration issues of medicines with poor palatability.

Rouse C, Mistry P, Rayner O, Nickless J, Wan M, Southern KW, Batchelor HK. Rouse C, et al. Among authors: rayner o. Int J Pharm Pract. 2017 Oct;25(5):326-334. doi: 10.1111/ijpp.12308. Epub 2016 Sep 16. Int J Pharm Pract. 2017. PMID: 27633317 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page